- PR Newswire•2 days ago
BEIJING, Oct. 24, 2016 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company ...
- Capital Cube•14 days agoChina Biologic Products, Inc. breached its 50 day moving average in a Bearish Manner : CBPO-US : October 12, 2016
Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for China Biologic Products, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day ... Read more (Read more...)
- PR Newswire•15 days ago
BEIJING, Oct. 11, 2016 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that Shandong Taibang Biological Products Co. Ltd., the Company's majority-owned subsidiary, recently obtained approval from the China Food and Drug Administration (the "CFDA") to begin human clinical trials on its Human Antithrombin III ("ATIII") product. ATIII is intended to treat hereditary and acquired ATIII deficiency in connection with surgical or obstetrical procedures, and to treat thromboembolism.
China Biologic Products, Inc. (CBPO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||100.18 x 200|
|Day's Range||112.75 - 114.94|
|52wk Range||100.53 - 144.29|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||33.14|
|Avg Vol (3m)||213,290|
|Dividend & Yield||N/A (N/A)|